State Street
NMTR

State Street’s 9 Meters Biopharma NMTR Stock Holding History

State Street’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-50,908
Closed -$34.2K – 4703
2023
Q2 		$34.2K Hold
50,908
– – ﹤0.01% 4514
2023
Q1 		$70.8K Hold
50,908
– – ﹤0.01% 4418
2022
Q4 		$64.1K Buy
50,908
+10,599
+26% +$24.2K ﹤0.01% 4494
2022
Q3 		$173K Hold
40,309
– – ﹤0.01% 4214
2022
Q2 		$210K Sell
40,309
-151,187
-79% -$1.42M ﹤0.01% 4175
2022
Q1 		$2.29M Buy
191,496
+4,590
+2% +$62.7K ﹤0.01% 3508
2021
Q4 		$3.66M Buy
186,906
+12,748
+7% +$285K ﹤0.01% 3387
2021
Q3 		$4.53M Buy
174,158
+25,318
+17% +$597K ﹤0.01% 3291
2021
Q2 		$3.27M Buy
+148,840
New +$3.65M ﹤0.01% 3427
2019
Q2 		– Sell
-12,784
Closed -$493K – 3861
2019
Q1 		$493K Buy
12,784
+106
+0.8% +$4.58K ﹤0.01% 3448
2018
Q4 		$586K Sell
12,678
-540
-4% -$40K ﹤0.01% 3425
2018
Q3 		$1.8M Buy
13,218
+5,779
+78% +$993K ﹤0.01% 3284
2018
Q2 		$3.51M Buy
+7,439
New +$2.74M ﹤0.01% 3031

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

State Street's NMTR Position: Q3 2023 in Review

State Street sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 50,908 shares — an estimated $34.2K sold.

State Street first reported a position in NMTR in Q2 2018 and held it in 13 quarters. The position peaked at $4.53M in Q3 2021. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • State Street reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • State Street sold 50,908 9 Meters Biopharma shares in Q3 2023, an estimated $34.2K.
  • State Street first reported a position in 9 Meters Biopharma in Q2 2018 and held it in 13 quarters.
  • State Street's 9 Meters Biopharma position peaked at $4.53M in Q3 2021.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.